Samsung Pharm Co Ltd has announced that the company presented the results of phase III clinical trial of its pancreatic cancer immunotherapeutic drug candidate called ‘RIAVAX™ (GV1001)’ conducted in Korea at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting. ASCO 2021, which celebrates its 57th anniversary this year, runs from June 4th to June 8th and will…
Bajaj Healthcare has reportedly launched Posaconazole API which is used in the treatment of mucormycosis (black fungus) infection in COVID-19 patients. According to reports, a regulatory filing by Bajaj Healthcare states that the company has received approval from FDA (Food and Drugs Administration) Gandhi Nagar, Gujarat, to manufacture and market Posaconazole API as approved medication…
Human Vaccine LLC, a wholly-owned subsidiary of the Russian Direct Investment Fund (RDIF – Russia’s sovereign wealth fund) has announced the signing of an agreement for the supply of 220 million doses of two-dose Sputnik V Russian COVID-19 vaccine with the United Nations International Children’s Emergency Fund (UNICEF). This amount is sufficient to vaccinate 110…
The Government of Haryana has partnered with Deloitte to launch Sanjeevani Pariyojana (the ‘life project’), a supervised, virtual home-care initiative to help people quickly access healthcare for mild-to-moderate symptoms of COVID-19. Sanjeevani Pariyojana provides individuals with support and resources to manage their care at home including access to virtual triage, as well as COVID-19 field hospitals and…
Global pharmaceutical company, Cadila Healthcare has announced the launch of Trastuzumab Emtansine, the first Antibody Drug Conjugate (ADC) biosimilar for treating both early and advanced HER2 positive breast cancer. The company will market the drug under the brand name Ujvira. HER2 positive breast cancer is considered an aggressive form and constitutes 20 to 25% of…
The Maharashtra government has told the Aurangabad bench of the Bombay High Court on Monday that the treatment of mucormycosis or black fungus, will now be treated for free under the Mahatma Jotiba Phule Jan Aarogya Yojana and the Pradhan Mantri Jan Arogya Yojana. According to reports, citizens will receive free treatment for mucormycosis at…
The first batch of the adjunct COVID therapy drug, 2-deoxy-D-glucose (2-DG) which was developed by the Defence Research and Development Organisation (DRDO) in partnership with Dr Reddy’s Laboratories (DRL), Hyderabad, was released on Monday for emergency use. An anti-COVID-19 therapeutic application of the drug 2-DG has been developed by the Institute of Nuclear Medicine and Allied…
“COVID-19 is a recent disease and at times it displays symptoms which no other viral infection does. While we are developing an understanding of the short and long-term impact on the body we now know that one may develop new symptoms six months to one year after recovering from COVID. The term given to this…
The office of Principal Scientific Advisor to the Government of India has reportedly released an advisory on stopping the spread of the SARS-CoV-2 virus. The advisory given by Professor K. Vijay Raghavan highlights the importance of well-ventilated places. He says that well-ventilated spaces dilute the viral load of infected air in poorly ventilated spaces like houses, offices etc. Proper ventilation can…
Daniel B Smith, the Charge D’Affaires of the US embassy, said on Tuesday that the USA is looking for joint production of Johnson & Johnson Covid-19 vaccine in India and is also trying to figure out ways to boost manufacturing of the vaccines by vaccine producers like the Serum Institute of India (SII). In an announcement last month, the White…